Until the late 1990s, the treatment of Crohn’s disease predominantly involved the use of steroids, 5-aminosalicylates (5-ASAs), and antimetabolites. However, patients often fail to achieve and maintain response and remission with these therapies. The majority of patients eventually need corticosteroids to manage the disease, and these are associated with potentially serious side effects [1].